By: Meghavi Singh
VYNE Therapeutics ( VYNE ) declares $0.38/share special dividend in connection with its pending merger with Yarrow Bioscience, Inc., originally agreed upon on December 17, 2025.
Meghavi Singh is a News Editor at NewsBreak. She specializes in finance-related topics, including trading, personal finance, commodities and futures, and the broader financial markets. Meghavi's insights and analyses have been featured in prominent publications such as NewsBreak, The New York Ledger, and Seeking Alpha.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston


Not enough data
This information evolves through artificial intelligence and human feedback. Improve this profile .